HABTOOR Leighton Group (HLG), operating as Leighton Middle East Contracting, has been awarded a healthcare project worth SR1.18 billion ($316 million) at King Fahad Medical City in Saudi Arabia.

The project, referred to as PPNNCC, will be delivered in a joint venture with Al Latifia Trading and Contracting.

Located in the heart of Riyadh, PPNNCC involves the construction of new medical centres at the current King Fahad Medical City campus in order to integrate them with existing medical facilities.

HLG chief executive officer and managing director Laurie Voyer said: “Saudi Arabia is our largest growth market, and this project underlines our ability to secure work there.”

HLG’s new managing director-elect, Jose Antonio Lopez-Monis, said the medical project, which will be the first of five specialist hospitals to be built in Saudi Arabia over the next five years, will see the delivery of state-of-the-art medical facilities.

The group’s scope of work consists of the development of facilities like a national 11-storey neurosciences institute, a 11-storey comprehensive cancer centre, a three-storey cardiac centre, a seven-storey laboratories and office building in addition to a two-level car-park in the basement. Additionally, the 234,000-sq-m project proposes the construction of central services building spanning four levels, and a services tunnel approximately 320 m in length. It will also house a Proton lab, which HLG is likely to deliver under a separate contract.

Works will commence later this year, with the project to be delivered in stages over the next three years.